Catalysts for $NVO
44 tracked
Nov 4, 2026
earnings
NOVO NORDISK A S earnings
NOVO NORDISK A S
β
Aug 5, 2026
earnings
NOVO NORDISK A S earnings
NOVO NORDISK A S
β
May 6, 2026
earnings
NOVO NORDISK A S earnings
NOVO NORDISK A S
β
Mar 26, 2026
approval
AWIQLI FLEXTOUCH (INSULIN ICODEC) β FDA approval
insulin icodec
β
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Jan 7, 2026
recall
Novo Nordisk Inc. recall (Cls II)
NOVO NORDISK A S
β
Jan 7, 2026
recall
Novo Nordisk Inc. recall (Cls II)
NOVO NORDISK A S
β
Oct 14, 2025
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Jul 9, 2025
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
May 28, 2025
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Feb 12, 2025
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Jan 31, 2025
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Nov 1, 2024
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Jul 5, 2023
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Apr 28, 2023
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Jun 10, 2022
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Jun 10, 2022
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Oct 1, 2021
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Oct 1, 2021
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Nov 20, 2020
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Aug 28, 2020
approval
SOGROYA (SOMAPACITAN-BECO) β FDA approval
somatriptan albumin bound LA
β
Aug 5, 2020
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Jun 17, 2019
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Aug 25, 2017
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Jul 26, 2017
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Apr 25, 2017
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Sep 20, 2016
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β
Apr 22, 2016
approval
VICTOZA (LIRAGLUTIDE) β FDA approval
Saxenda
β